Cargando…

Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study

BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a newly identified and serious health condition associated with SARS-CoV-2 infection. Clinical manifestations vary widely among patients with MIS-C, and the aim of this study was to investigate factors associated with severe outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Abrams, Joseph Y, Oster, Matthew E, Godfred-Cato, Shana E, Bryant, Bobbi, Datta, S Deblina, Campbell, Angela P, Leung, Jessica W, Tsang, Clarisse A, Pierce, Timmy J, Kennedy, Jordan L, Hammett, Teresa A, Belay, Ermias D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943393/
https://www.ncbi.nlm.nih.gov/pubmed/33711293
http://dx.doi.org/10.1016/S2352-4642(21)00050-X
_version_ 1783662482035834880
author Abrams, Joseph Y
Oster, Matthew E
Godfred-Cato, Shana E
Bryant, Bobbi
Datta, S Deblina
Campbell, Angela P
Leung, Jessica W
Tsang, Clarisse A
Pierce, Timmy J
Kennedy, Jordan L
Hammett, Teresa A
Belay, Ermias D
author_facet Abrams, Joseph Y
Oster, Matthew E
Godfred-Cato, Shana E
Bryant, Bobbi
Datta, S Deblina
Campbell, Angela P
Leung, Jessica W
Tsang, Clarisse A
Pierce, Timmy J
Kennedy, Jordan L
Hammett, Teresa A
Belay, Ermias D
author_sort Abrams, Joseph Y
collection PubMed
description BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a newly identified and serious health condition associated with SARS-CoV-2 infection. Clinical manifestations vary widely among patients with MIS-C, and the aim of this study was to investigate factors associated with severe outcomes. METHODS: In this retrospective surveillance study, patients who met the US Centers for Disease Control and Prevention (CDC) case definition for MIS-C (younger than 21 years, fever, laboratory evidence of inflammation, admitted to hospital, multisystem [≥2] organ involvement [cardiac, renal, respiratory, haematological, gastrointestinal, dermatological, or neurological], no alternative plausible diagnosis, and either laboratory confirmation of SARS-CoV-2 infection by RT-PCR, serology, or antigen test, or known COVID-19 exposure within 4 weeks before symptom onset) were reported from state and local health departments to the CDC using standard case-report forms. Factors assessed for potential links to severe outcomes included pre-existing patient factors (sex, age, race or ethnicity, obesity, and MIS-C symptom onset date before June 1, 2020) and clinical findings (signs or symptoms and laboratory markers). Logistic regression models, adjusted for all pre-existing factors, were used to estimate odds ratios between potential explanatory factors and the following outcomes: intensive care unit (ICU) admission, shock, decreased cardiac function, myocarditis, and coronary artery abnormalities. FINDINGS: 1080 patients met the CDC case definition for MIS-C and had symptom onset between March 11 and Oct 10, 2020. ICU admission was more likely in patients aged 6–12 years (adjusted odds ratio 1·9 [95% CI 1·4–2·6) and patients aged 13–20 years (2·6 [1·8–3·8]), compared with patients aged 0–5 years, and more likely in non-Hispanic Black patients, compared with non-Hispanic White patients (1·6 [1·0–2·4]). ICU admission was more likely for patients with shortness of breath (1·9 [1·2–2·9]), abdominal pain (1·7 [1·2–2·7]), and patients with increased concentrations of C-reactive protein, troponin, ferritin, D-dimer, brain natriuretic peptide (BNP), N-terminal pro B-type BNP, or interleukin-6, or reduced platelet or lymphocyte counts. We found similar associations for decreased cardiac function, shock, and myocarditis. Coronary artery abnormalities were more common in male patients (1·5 [1·1–2·1]) than in female patients and patients with mucocutaneous lesions (2·2 [1·3–3·5]) or conjunctival injection (2·3 [1·4–3·7]). INTERPRETATION: Identification of important demographic and clinical characteristics could aid in early recognition and prompt management of severe outcomes for patients with MIS-C. FUNDING: None.
format Online
Article
Text
id pubmed-7943393
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd
record_format MEDLINE/PubMed
spelling pubmed-79433932021-03-11 Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study Abrams, Joseph Y Oster, Matthew E Godfred-Cato, Shana E Bryant, Bobbi Datta, S Deblina Campbell, Angela P Leung, Jessica W Tsang, Clarisse A Pierce, Timmy J Kennedy, Jordan L Hammett, Teresa A Belay, Ermias D Lancet Child Adolesc Health Articles BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C) is a newly identified and serious health condition associated with SARS-CoV-2 infection. Clinical manifestations vary widely among patients with MIS-C, and the aim of this study was to investigate factors associated with severe outcomes. METHODS: In this retrospective surveillance study, patients who met the US Centers for Disease Control and Prevention (CDC) case definition for MIS-C (younger than 21 years, fever, laboratory evidence of inflammation, admitted to hospital, multisystem [≥2] organ involvement [cardiac, renal, respiratory, haematological, gastrointestinal, dermatological, or neurological], no alternative plausible diagnosis, and either laboratory confirmation of SARS-CoV-2 infection by RT-PCR, serology, or antigen test, or known COVID-19 exposure within 4 weeks before symptom onset) were reported from state and local health departments to the CDC using standard case-report forms. Factors assessed for potential links to severe outcomes included pre-existing patient factors (sex, age, race or ethnicity, obesity, and MIS-C symptom onset date before June 1, 2020) and clinical findings (signs or symptoms and laboratory markers). Logistic regression models, adjusted for all pre-existing factors, were used to estimate odds ratios between potential explanatory factors and the following outcomes: intensive care unit (ICU) admission, shock, decreased cardiac function, myocarditis, and coronary artery abnormalities. FINDINGS: 1080 patients met the CDC case definition for MIS-C and had symptom onset between March 11 and Oct 10, 2020. ICU admission was more likely in patients aged 6–12 years (adjusted odds ratio 1·9 [95% CI 1·4–2·6) and patients aged 13–20 years (2·6 [1·8–3·8]), compared with patients aged 0–5 years, and more likely in non-Hispanic Black patients, compared with non-Hispanic White patients (1·6 [1·0–2·4]). ICU admission was more likely for patients with shortness of breath (1·9 [1·2–2·9]), abdominal pain (1·7 [1·2–2·7]), and patients with increased concentrations of C-reactive protein, troponin, ferritin, D-dimer, brain natriuretic peptide (BNP), N-terminal pro B-type BNP, or interleukin-6, or reduced platelet or lymphocyte counts. We found similar associations for decreased cardiac function, shock, and myocarditis. Coronary artery abnormalities were more common in male patients (1·5 [1·1–2·1]) than in female patients and patients with mucocutaneous lesions (2·2 [1·3–3·5]) or conjunctival injection (2·3 [1·4–3·7]). INTERPRETATION: Identification of important demographic and clinical characteristics could aid in early recognition and prompt management of severe outcomes for patients with MIS-C. FUNDING: None. Elsevier Ltd 2021-05 2021-03-10 /pmc/articles/PMC7943393/ /pubmed/33711293 http://dx.doi.org/10.1016/S2352-4642(21)00050-X Text en Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Articles
Abrams, Joseph Y
Oster, Matthew E
Godfred-Cato, Shana E
Bryant, Bobbi
Datta, S Deblina
Campbell, Angela P
Leung, Jessica W
Tsang, Clarisse A
Pierce, Timmy J
Kennedy, Jordan L
Hammett, Teresa A
Belay, Ermias D
Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study
title Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study
title_full Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study
title_fullStr Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study
title_full_unstemmed Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study
title_short Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study
title_sort factors linked to severe outcomes in multisystem inflammatory syndrome in children (mis-c) in the usa: a retrospective surveillance study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943393/
https://www.ncbi.nlm.nih.gov/pubmed/33711293
http://dx.doi.org/10.1016/S2352-4642(21)00050-X
work_keys_str_mv AT abramsjosephy factorslinkedtosevereoutcomesinmultisysteminflammatorysyndromeinchildrenmiscintheusaaretrospectivesurveillancestudy
AT ostermatthewe factorslinkedtosevereoutcomesinmultisysteminflammatorysyndromeinchildrenmiscintheusaaretrospectivesurveillancestudy
AT godfredcatoshanae factorslinkedtosevereoutcomesinmultisysteminflammatorysyndromeinchildrenmiscintheusaaretrospectivesurveillancestudy
AT bryantbobbi factorslinkedtosevereoutcomesinmultisysteminflammatorysyndromeinchildrenmiscintheusaaretrospectivesurveillancestudy
AT dattasdeblina factorslinkedtosevereoutcomesinmultisysteminflammatorysyndromeinchildrenmiscintheusaaretrospectivesurveillancestudy
AT campbellangelap factorslinkedtosevereoutcomesinmultisysteminflammatorysyndromeinchildrenmiscintheusaaretrospectivesurveillancestudy
AT leungjessicaw factorslinkedtosevereoutcomesinmultisysteminflammatorysyndromeinchildrenmiscintheusaaretrospectivesurveillancestudy
AT tsangclarissea factorslinkedtosevereoutcomesinmultisysteminflammatorysyndromeinchildrenmiscintheusaaretrospectivesurveillancestudy
AT piercetimmyj factorslinkedtosevereoutcomesinmultisysteminflammatorysyndromeinchildrenmiscintheusaaretrospectivesurveillancestudy
AT kennedyjordanl factorslinkedtosevereoutcomesinmultisysteminflammatorysyndromeinchildrenmiscintheusaaretrospectivesurveillancestudy
AT hammettteresaa factorslinkedtosevereoutcomesinmultisysteminflammatorysyndromeinchildrenmiscintheusaaretrospectivesurveillancestudy
AT belayermiasd factorslinkedtosevereoutcomesinmultisysteminflammatorysyndromeinchildrenmiscintheusaaretrospectivesurveillancestudy